Search

everythinglearnresearchcommunity

for

Search:↓

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Genetic testing is crucial before giving azathioprine to avoid severe side effects.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Valproic acid increases hair count in men with hair loss.

Early recognition and treatment of tinea capitis are crucial to prevent severe scalp issues and prolonged therapy.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Malarone® caused pancreatitis and hair loss in a dog for the first time.

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Helmet-like device safely increases hair density for people with hair loss.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Tailored nonsurgical cosmetic procedures are crucial for safely treating diverse skin types, especially skin of color.

Rose stem cell exosomes can significantly improve hair growth in androgenetic alopecia.

A new hand-held light therapy device was found to be safe and effective for treating mild-to-moderate acne.

Use NSAIDs for immediate migraine relief and β-blockers for prevention; tailor treatment to the individual.

JAK inhibitors show promise for treating various skin diseases.

The supplement significantly improves hair density and appearance in people with hair loss.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.